Skip to main content

Forward Pharma A/S (FWP)

NASDAQ: FWP · IEX Real-Time Price · USD
6.90 0.11 (1.62%)
Oct 25, 2021 4:00 PM EDT - Market closed
Market Cap48.45M
Revenue (ttm)n/a
Net Income (ttm)-6.45M
Shares Out7.02M
EPS (ttm)-0.79
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume36,095
Open6.82
Previous Close6.79
Day's Range6.70 - 6.97
52-Week Range5.76 - 20.31
Beta1.75
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About FWP

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

IndustryBiotechnology
Founded2005
CEOClaus Svendsen
Employees4
Stock ExchangeNASDAQ
Ticker SymbolFWP
Full Company Profile

Financial Performance

Financial Statements

News

Why is Forward Pharma Stock Plunging During Premarket Tuesday?

The stock price of Forward Pharma A/S (NASDAQ: FWP) fell by almost 20% during the premarket.  Investors are responding negatively to the Technical Board of Appeal (TBA) of the European Patent Office (EP...

1 month ago - Benzinga

Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355...

COPENHAGEN, Denmark, Sept. 06, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that the Technical Board of Appeal (the “TBA”) of the European...

1 month ago - GlobeNewsWire

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020

COPENHAGEN, Denmark, April 14, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated f...

6 months ago - GlobeNewsWire

Forward Pharma Announces Rescheduling of the EP2801355 Appeal Hearing to September 6, 2021 due to COVID-19 Restrictions

COPENHAGEN, Denmark, Jan. 12, 2021 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to ongoing precautionary measures against the spread o...

9 months ago - GlobeNewsWire

A Trio of Stock Picks for the Short-Term Investor

There are investors who purchase shares of stocks that are trading below their liquidation value in the belief that they can make huge gains out of their investments after the market has reassessed the ...

Other symbols:APWC
1 year ago - GuruFocus

Forward Pharma: Heads You Win Big, Tails You Still Win

Forward Pharma: Heads You Win Big, Tails You Still Win

1 year ago - Seeking Alpha

Forward Pharma A/S Announces Change in Ratio of American Depositary Shares to Ordinary Shares

COPENHAGEN, Denmark, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that its Board of Directors has approved a change in the number of i...

1 year ago - GlobeNewsWire

Forward Pharma to Participate in the Fall Investor Summit in New York

COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fal...

2 years ago - GlobeNewsWire